# Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC

> **NCT05782426** · PHASE2 · UNKNOWN · sponsor: **Jiangsu Cancer Institute & Hospital** · enrollment: 28 (estimated)

## Conditions studied

- Non-squamous NSCLC

## Interventions

- **DRUG:** paclitaxel polymeric micelles for injection

## Key facts

- **NCT ID:** NCT05782426
- **Lead sponsor:** Jiangsu Cancer Institute & Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-15
- **Primary completion:** 2024-01-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2023-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05782426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05782426, "Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05782426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*